Page 8 - Path Inc News Today

Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have been assigned an average recommendation of “Hold” from the fifteen research firms that are presently covering the firm, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]

Needham & Company LLC reiterated their buy rating on shares of UiPath (NYSE:PATH – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $20.00 price target on the healthcare company’s stock. Several other equities analysts have also commented on the stock. Barclays upped their price objective on shares […]

Glass Jacobson Investment Advisors llc acquired a new stake in shares of UiPath Inc. (NYSE:PATH – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 57,445 shares of the healthcare company’s stock, valued at approximately $952,000. Other large investors also recently bought […]

Royal Bank of Canada restated their sector perform rating on shares of UiPath (NYSE:PATH – Free Report) in a research note published on Thursday morning, Benzinga reports. Royal Bank of Canada currently has a $19.00 target price on the healthcare company’s stock. Several other equities analysts also recently weighed in on PATH. Macquarie lifted their […]

Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month target price […]

Bangor Savings Bank raised its position in UiPath Inc. (NYSE:PATH – Free Report) by 109,876.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,487 shares of the healthcare company’s stock after buying an additional 60,432 shares during the quarter. Bangor […]

Invictus Private Wealth LLC boosted its holdings in UiPath Inc. (NYSE:PATH – Free Report) by 35.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 219,386 shares of the healthcare company’s stock after purchasing an additional 57,786 shares during the quarter. UiPath makes up 0.5% of Invictus Private Wealth LLC’s portfolio, making the stock […]

UiPath (NYSE:PATH – Free Report) had its price objective upped by DA Davidson from $16.00 to $17.00 in a research report sent to investors on Thursday, Marketbeat.com reports. The brokerage currently has a neutral rating on the healthcare company’s stock. Several other equities analysts have also recently weighed in on PATH. Bank of America raised […]

UiPath (NYSE:PATH – Free Report) had its price target boosted by Royal Bank of Canada from $18.00 to $19.00 in a research report released on Thursday, MarketBeat reports. The firm currently has a sector perform rating on the healthcare company’s stock. Several other brokerages have also issued reports on PATH. Wells Fargo & Company lowered […]

Needham & Company LLC reissued their buy rating on shares of UiPath (NYSE:PATH – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $20.00 price objective on the healthcare company’s stock. A number of other brokerages have also recently commented on PATH. Barclays boosted their price objective on UiPath […]